300313 *ST天山生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)12.171-195.127-225.890-30.069-33.810
总资产报酬率 ROA (%)1.448-10.301-23.410-6.793-8.700
投入资产回报率 ROIC (%)2.039-19.257-55.083-13.037-14.583

边际利润分析
销售毛利率 (%)9.8557.398-5.23016.98614.166
营业利润率 (%)4.987-10.965-44.576-13.572-36.988
息税前利润/营业总收入 (%)6.250-6.329-38.280-6.278-21.879
净利润/营业总收入 (%)4.085-13.076-48.748-16.061-41.952

收益指标分析
经营活动净收益/利润总额(%)65.212100.94173.16880.28973.521
价值变动净收益/利润总额(%)19.193-15.424-5.374-15.06926.411
营业外收支净额/利润总额(%)-0.211-0.0073.2553.3407.324

偿债能力分析
流动比率 (X)1.1941.8130.3210.4840.521
速动比率 (X)0.7681.2150.2260.1680.281
资产负债率 (%)82.61384.06797.71177.16271.714
带息债务/全部投入资本 (%)27.5568.05885.08150.43447.535
股东权益/带息债务 (%)62.728200.677-5.12680.67495.850
股东权益/负债合计 (%)15.07013.461-1.55825.55935.290
利息保障倍数 (X)4.907-1.365-4.910-0.809-1.213

营运能力分析
应收账款周转天数 (天)20.02831.79534.04125.98482.715
存货周转天数 (天)31.33850.521113.040199.698228.050